The serums were treated with magnetic beads coupled with DTT to remove antibodies against DTT, and then the antibody titer and absorbance (1:200 dilutions) after each treatment were detected by ELISA. Secondary antibodies used were goat anti-mouse IgG-HRP, or goat anti-mouse IgG1-HRP, or IgG2b-HRP, or IgG2c-HRP, or IgG3-HRP, or IgM-HRP (1:5000 dilutions, Shanghai Immune Biotech Co. Ltd., Shanghai, China), and 3, 3′, 5, 5′-tetramethylbenzidine (
TMB, TIANGEN, Beijing, China) as the substrate agent. The absorbance at 450 nm was measured by
EnSpire 2300 ELISA reader (PerkinElmer, Waltham, MA, USA).
The amount of IFN-γ secretion in the supernatants diluted 2-fold from ex vivo stimulation above were measured by sandwich ELISA using the
mouse IFN-γ DuoSet ELISA kits (R&D Systems) following the manufacturer’s instruction. All standards and samples were assayed in duplicate and data were analyzed in Microplate Reader with a 6-parameter fit for the standard curve.
To assess inflammatory reactions, IL-6 and IL-8 concentrations of serum from mice treated with DTT-COS1, DTT-COS2, DTT-COS12, or PBS were measured by Mouse IL-6 ELISA Kit (BOS-20268) and Mouse IL-6 ELISA Kit (BOS-46967) following the manufacturer’s instruction. The absorbance at 450 nm was measured by
EnSpire 2300 ELISA reader (PerkinElmer, Waltham, MA, USA).
Cai H., Wang W., Lin Z., Zhang Y., Wu B., Wan Y, & Li R. (2020). Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 Melanoma. Vaccines, 8(2), 223.